Application of phloretin to preparation of colitis preventing and treating drug

A technology of colitis and phloretin, which is applied in the field of application of phloretin in the preparation of drugs for the prevention and treatment of colitis, and can solve the problems that glucocorticoids are easy to cause obesity, patients are difficult to maintain long-term treatment, and adverse reactions are prone to occur , to achieve no adverse reactions and side effects, improve the pathological damage of colonic tissue, and reduce the effect of disease activity index

Inactive Publication Date: 2019-02-22
XINXIANG MEDICAL UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] above, but the incidence of adverse reactions such as nausea, vomiting, headache, and loss of appetite is relatively high; (2) glucocorticoids are the most effective for inhibiting acute active inflammation in UC, but they have no maintenance effect, and glucocorticoids ar

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of phloretin to preparation of colitis preventing and treating drug
  • Application of phloretin to preparation of colitis preventing and treating drug
  • Application of phloretin to preparation of colitis preventing and treating drug

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0017] In order to make the objectives, technical solutions, and advantages of the present invention clearer, the following embodiments will further describe the present invention in detail. It should be understood that the specific embodiments described herein are only used to explain the present invention, but not to limit the present invention.

[0018] Phloretin (Phloretin) belongs to the dihydrochalcone compound. It is a natural active substance present in the root bark of juicy fruits such as apples and pears. The structural formula of the phloretin monomer of the present invention is as follows:

[0019]

[0020] The present invention verifies the preventive and therapeutic effects of phloretin on ulcerative colitis through two sets of experiments. The specific experimental plan is as follows:

[0021] The first part of the experimental program: the preventive effect of phloretin on ulcerative colitis

[0022] In the present invention, an animal model of ulcerative colitis indu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an application of phloretin to preparation of an ulcerative colitis preventing and treating drug. According to the application of phloretin to the ulcerative colitis preventingand treating drug, the phloretin can prevent and treat ulcerative colitis, has no adverse reactions or side effects and has a maintained effect.

Description

technical field [0001] The invention relates to the field of biopharmaceuticals, in particular to the application of phloretin in the preparation of drugs for preventing and treating colitis. Background technique [0002] Ulcerative colitis (UC) is a chronic non-specific intestinal disease of unknown cause. The lesions are mainly located in the mucosal layer of the colon, often involving the rectum and distal colon, and can also spread throughout the colon, showing continuous diffusion. sex distribution. The disease is seen at any age, and is more common in the age of 25-40. Except for a few patients with sudden onset, most patients have a slow onset, and the severity of the disease varies. Abdominal pain, diarrhea, mucus and bloody stools, and tenesmus were the main clinical symptoms. Histopathological manifestations were submucosal edema, inflammatory cell infiltration, decreased goblet cells, and decreased number of crypts. Endoscopic colon showed erosions, ulcers, and o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/12A61P1/00A61P1/04
CPCA61K31/12A61P1/00A61P1/04
Inventor 吴敏娜李璞泽钟根深闫冬李敏
Owner XINXIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products